How good enough are the new therapies for lupus nephritis? A narrative review and a position paper

Frédéric A Houssiau1

  • 1Service de Rhumatologie, Cliniques universitaires Saint-Luc, Brussels, Belgium; Institut de Recherche Expérimentale et Clinique, UCLouvain, Belgium.

PubMed

Insights

New lupus nephritis therapies offer hope after years of failures. Combination treatments are recommended to prevent chronic kidney disease, with future research exploring cellular therapy.

Area of Science:

  • Nephrology
  • Immunology
  • Rheumatology

Background:

  • Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus, often leading to kidney failure.
  • Therapeutic options for LN have historically been limited, with many clinical trials failing to yield effective treatments.
  • Significant advancements have recently emerged, offering new hope for patients with this debilitating condition.

Purpose of the Study:

  • To provide a narrative review of recent therapeutic developments in lupus nephritis.
  • To comment on the efficacy and application of novel LN therapies.
  • To emphasize the role of combination therapy in managing LN and preventing chronic kidney disease progression.

Main Methods:

  • Narrative review of literature and clinical experience spanning nearly four decades.
  • Analysis of recently approved and emerging therapies for lupus nephritis.
  • Discussion of expert recommendations regarding combination therapy and future research directions.

Main Results:

  • Several new therapies have become available for lupus nephritis following numerous trial failures.
  • Combination therapy is increasingly recommended to mitigate the risk of chronic kidney disease.
  • Early cellular therapy approaches are reviewed, with potential for future research.

Conclusions:

  • Recent therapeutic advancements represent a significant breakthrough in lupus nephritis management.
  • Combination therapy is crucial for improving long-term renal outcomes in LN patients.
  • Further research, particularly in cellular therapy, is warranted to enhance treatment strategies for lupus nephritis.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
866
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
424
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
561
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
702